Verfahren zur Detektion von Mutationen in den Genen IL28B (RS8099917) und ITPA (RS1127354)

EP2570492 Art B1 16. Juli 2014

Anmelder: ARKRAY, Inc. 🇯🇵

Details

Veröffentlichungs-Nr.
EP2570492
Aktenzeichen
EP12184426
Anmeldetag
14. September 2012
Veröffentlichung
16. Juli 2014
Erteilung
16. Juli 2014
Rechtsraum
EP
IPC
C12Q1/68
Offizieller Volltext

Abstract

A probe for detecting a polymorphism in the IL28B gene, comprising the fluorescently labeled oligonucleotide P1 or P1' below: (P1) an oligonucleotide comprising a nucleotide sequence of 7 to 28 consecutive nucleotides containing nucleotides 301 to 307 in SEQ ID NO:1 or a homologous sequence thereof, wherein the nucleotide corresponding to the nucleotide at position 307 is a cytosine and is labeled with a fluorescent dye; (P1') an oligonucleotide comprising a nucleotide sequence of 7 to 28 consecutive nucleotides containing nucleotides 301 to 307 in SEQ ID NO:1 or a nucleotide sequence which hybridizes with the complementary strand of SEQ ID NO:1 under stringent conditions, wherein the nucleotide corresponding to the nucleotide at position 307 is a cytosine and is labeled with a fluorescent dye. A probe for detecting a polymorphism in the ITPA gene, comprising at least one fluorescently labeled oligonucleotide selected from P2 to P3' below: (P2) an oligonucleotide comprising a complement of a nucleotide sequence of 13 to 28 consecutive nucleotides containing nucleotides 239 to 251 in SEQ ID NO:2 or a homologous sequence thereof, wherein the nucleotide corresponding (i.e. complementary) to the nucleotide at position 239 is a cytosine and is labeled with a fluorescent dye; (P2') an oligonucleotide comprising a nucleotide sequence which hybridizes with a nucleotide sequence of 13 to 28 consecutive nucleotides containing nucleotides 239 to 251 in SEQ ID NO:2 under stringent conditions, wherein the nucleotide corresponding (i.e. complementary) to the nucleotide at position 239 is a cytosine and is labeled with a fluorescent dye; (P3) an oligonucleotide comprising a nucleotide sequence of 6 to 42 consecutive nucleotides containing nucleotides 251 to 256 in SEQ ID NO:2 or a homologous sequence thereof, wherein the nucleotide corresponding to the nucleotide at position 256 is a cytosine and is labeled with a fluorescent dye; (P3') an oligonucleotide comprising a nucleotide sequence of 6 to 42 consecutive nucleotides containing nucleotides 251 to 256 in SEQ ID NO:2 or a nucleotide sequence which hybridizes with the complementary strand of SEQ ID NO: 2 under stringent conditions, wherein the nucleotide corresponding to the nucleotide at position 256 is a cytosine and is labeled with a fluorescent dye.

Anmelder

Firma
ARKRAY, Inc.
Land
🇯🇵 Japan
🇯🇵 Arkray

Japanisches Unternehmen mit Sitz in Kyoto, das medizinische Diagnosegeräte herstellt, insbesondere Blutzuckermessgeräte und klinische Labordiagnostik.

793 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen